Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

7 Stocks Most at Risk of a Capital Gains Tax Selloff 

By Chris Lau, InvestorPlace Contributor

A big capital gains tax is looming, threatening to trigger a selloff on companies whose stock ran up the most.

Stem Stock Is Falling, but Its First-Mover Advantage Is Worth Remembering

By Chris Lau, InvestorPlace Contributor

STEM stock is well off the peak as markets sold off SPAC stocks but the AI software-driven platform for clean energy shows promise

Ocugen Stock Has a Big Pullback Coming, and That Will Be Your Chance

By Chris Lau, InvestorPlace Contributor

OGCN Stock had a nice run in recent weeks but faces risks of a sharp pullback that could lead to paper losses for speculators.

Why FuboTV Stock Can Surge Almost 30%

By Chris Lau, InvestorPlace Contributor

FUBO stock is stuck in a downtrend after peaking at over $60, so if Fubo provides sports gambling opportunities, investors will get rewarded.

Why Canoo Stock Looks Like a Dangerous Gamble

By Chris Lau, InvestorPlace Contributor

Canoo posted no revenue in Q4 and promises only inexpensive EVs sometime in the future.

Load More